Abstract
Now that growth hormone can be produced in almost unlimited quantities, clinicians face difficult new questions: How does one decide which short children should be treated? Is it appropriate or ethical to prescribe GH for short children who do not have GH deficiency? Will such treatment produce taller adults? And what will be the side effects?